Castleark Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
Castleark Management's VCYT Position: Q2 2025 in Review
Castleark Management sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 195,010 shares — an estimated $5.78M sold.
Castleark Management first reported a position in VCYT in Q1 2019 and held it in 14 quarters. The position peaked at $12.3M in Q4 2020. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.
- Castleark Management reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
- Castleark Management sold 195,010 Veracyte shares in Q2 2025, an estimated $5.78M.
- Castleark Management first reported a position in Veracyte in Q1 2019 and held it in 14 quarters.
- Castleark Management's Veracyte position peaked at $12.3M in Q4 2020.
- 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.
Based on Castleark Management's 13F filing for Q2 2025, filed 18 Aug 2025.